# Single Dose Study of SHR4640 in Healthy Subjects

> **NCT02815839** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 50 (actual)

## Conditions studied

- Gout; Hyperuricemia

## Interventions

- **DRUG:** SHR4640
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02815839
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815839, "Single Dose Study of SHR4640 in Healthy Subjects". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT02815839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*